Cholesteryl ester transfer protein as a protective factor against vascular disease in hemodialysis patients

American Journal of Kidney Diseases

Volumn 38, Issue 1, 2001, Pages 70-76

  Kimura, Hideki ^a   Miyazaki, Ryoichi ^a   Suzuki, Satoru ^a   Gejyo, Fumitake ^a   Yoshida, Haruyoshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Atherosclerosis; Cholesteryl ester transfer protein (CETP); Hemodialysis (HD) patients; High density lipoprotein cholesterol (HDL C); Interaction

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROTECTIVE AGENT;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTPRANDIAL STATE; PREVALENCE; PROTEIN INTERACTION; REGRESSION ANALYSIS; RISK FACTOR; VASCULAR DISEASE;

EID: 0034973869     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.25196     Document Type: Article

References (29)

1. Accelerated atherosclerosis in prolonged maintenance hemodialysis
2. Cardiovascular complications in renal failure
3. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure
4. Reassessing the cardiac risk profile in chronic hemodialysis patients: Hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors
5. Impaired metabolism of high-density lipoprotein in uremic patients
6. Molecular physiology of reverse cholesterol transport
7. Plasma cholesteryl ester transfer protein
8. Reverse cholesterol transport - A review of the process and its clinical implications
9. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL
10. Plasma high-density lipoprotein concentration and development of ischemic heart disease
11. High-density lipoprotein cholesterol - The clinical implications of recent studies
12. Lipoprotein abnormalities in the pathogenesis of cerebral infarction and transient ischemic attack
13. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein sub-classes and coronary heart disease risk: The Framingham study
14. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis
15. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene
16. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels
17. A cholesteryl ester transfer protein gene mutation and disease in dialysis patients
18. Multicenter study of a new enzymatic method of cholesterol determination
19. Postprandial plasma lipoprotein changes in human subjects of different ages
20. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects
21. CETP is a determinant of serum LDL-cholesterol but not HDL-cholesterol in healthy Japanese
22. Cholesteryl ester transfer protein gene polymorprisms are associated with carotid atherosclerosis in men
23. Changes in cholesteryl ester transfer protein activity during normal gestation and postpartum
24. Neutral-lipid transfers and cholesteryl ester transfer protein in hemodialyzed patients
25. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase
26. Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes
27. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice
28. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I